AstraZeneca opens a $300 million cell therapy manufacturing facility in Rockville, boosting the local biotech industry.

A long-awaited trade deal has been struck between the UK and the US, but how much will FTSE 100 stocks benefit from the ...

Ministers are reviewing a controversial medicine tax that pharmaceutical companies say makes Britain 'uninvestable' as part ...

Professional analysts at Barclays Capital have reiterated their Buy ratings on these proven UK shares, so should investors ...

U.K. trade deal came in an email from the White House on pharmaceuticals. The upshot -- once the U.S. comes up with tariffs on pharmaceuticals, the U.K. drug industry will quickly get lowered rates.

(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

Durvalumab plus full BCG significantly improved disease-free survival in high-risk early bladder cancer vs BCG alone in the ...

Michael Hakes, senior portfolio manager at Murray Wealth Group, discusses his past stock picks and how they're doing in the ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the ...

US President Donald Trump and British Prime Minister Keir Starmer on Thursday announced a limited bilateral trade agreement that leaves in place Trump's 10% tariffs on British exports, modestly ...

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient ...